Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3711659014 | Pyrazinamide-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3711660016 | Product containing pyrazinamide in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pyrazinamide-containing product in oral dose form | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some | ||
| Pyrazinamide-containing product in oral dose form | Is a | Pyrazinamide-containing product | true | Inferred relationship | Some | ||
| Pyrazinamide-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some | ||
| Pyrazinamide-containing product in oral dose form | Has active ingredient | Pyrazinamide | true | Inferred relationship | Some | 1 | |
| Pyrazinamide-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pyrazinamide only product in oral dose form | Is a | True | Pyrazinamide-containing product in oral dose form | Inferred relationship | Some | |
| Pyrazinamide 500 mg oral tablet | Is a | False | Pyrazinamide-containing product in oral dose form | Inferred relationship | Some | |
| Isoniazid- and pyrazinamide- and rifampicin-containing product in oral dose form | Is a | True | Pyrazinamide-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR